Research graph

References

References from Cancer and Hypertension: Shared Mechanisms, Treatment Interactions, and Clinical Management. Local targets link to admitted publications; unresolved targets remain external evidence.

10.3322/caac.21262

10.3322/caac.21262 · External reference

10.1002/ijc.33588

10.1002/ijc.33588 · External reference

10.1038/s41571‐021‐00514‐z

10.1038/s41571‐021‐00514‐z · External reference

10.1038/s41371‐023‐00825‐x

10.1038/s41371‐023‐00825‐x · External reference

10.3390/ijms26010123

10.3390/ijms26010123 · External reference

10.1038/srep44877

10.1038/srep44877 · External reference

10.1161/hypertensionaha.111.189258

10.1161/hypertensionaha.111.189258 · External reference

10.1097/fjc.0000000000001342

10.1097/fjc.0000000000001342 · External reference

10.1007/s11906‐022‐01208‐2

10.1007/s11906‐022‐01208‐2 · External reference

10.1161/circresaha.121.318051

10.1161/circresaha.121.318051 · External reference

10.1038/s41585‐023‐00781‐8

10.1038/s41585‐023‐00781‐8 · External reference

10.1186/s12885‐025‐14406‐3

10.1186/s12885‐025‐14406‐3 · External reference

10.1097/cej.0000000000000578

10.1097/cej.0000000000000578 · External reference

10.3389/fendo.2023.1280060

10.3389/fendo.2023.1280060 · External reference

10.1038/s41598‐019‐45014‐4

10.1038/s41598‐019‐45014‐4 · External reference

10.1007/s10552‐023‐01797‐6

10.1007/s10552‐023‐01797‐6 · External reference

10.3390/medicina61050917

10.3390/medicina61050917 · External reference

10.1038/s41440‐024‐01660‐4

10.1038/s41440‐024‐01660‐4 · External reference

10.1093/ehjqcco/qcac016

10.1093/ehjqcco/qcac016 · External reference

10.1161/01.hyp.28.3.321

10.1161/01.hyp.28.3.321 · External reference

10.1161/circulationaha.115.020406

10.1161/circulationaha.115.020406 · External reference

Highlights of Mechanisms and Treatment of Obesity‐Related Hypertension

10.1038/s41371-021-00644-y · 2022 · External reference

Mechanisms Linking Obesity to Hypertension

10.1111/j.1467-789x.2011.00914.x · 2012 · External reference

Obesity and Hypertension

10.1016/j.phrs.2017.05.013 · 2017 · External reference

Body Fatness and Cancer — Viewpoint of the IARC Working Group

10.1056/nejmsr1606602 · 2016 · External reference

Body‐Mass Index and Incidence of Cancer: A Systematic Review and Meta‐Analysis of Prospective Observational Studies

10.1016/s0140-6736(08)60269-x · 2008 · External reference

Obesity and Cancer—Mechanisms Underlying Tumour Progression and Recurrence

10.1038/nrendo.2014.94 · 2014 · External reference

The Link Between Adipose Tissue Renin‐Angiotensin‐Aldosterone System Signaling and Obesity‐Associated Hypertension

10.1152/physiol.00037.2016 · 2017 · External reference

The Renin–Angiotensin System in Adipose Tissue and Its Metabolic Consequences During Obesity

10.1016/j.jnutbio.2013.07.002 · 2013 · External reference

The Renin–Angiotensin System and Cancer: Old Dog, New Tricks

10.1038/nrc2945 · 2010 · External reference

Mechanisms Linking the Renin‐Angiotensin System, Obesity, and Breast Cancer

10.1530/erc-19-0314 · 2019 · External reference

JSH2025 Guidelines for Hypertension Management in Older Adults: International Comparison

10.1038/s41440-026-02550-7 · 2026 · External reference

The Complex Interplay Between Aging and Cancer

10.1038/s43587-025-00827-z · 2025 · External reference

Cancer Incidence and Mortality Trends Among Older Adults

10.1038/s41514-025-00320-2 · 2026 · External reference

Proinflammatory Arterial Stiffness Syndrome: A Signature of Large Arterial Aging

10.1159/000490244 · 2018 · External reference

The Hallmarks of Aging

10.1016/j.cell.2013.05.039 · 2013 · External reference

Hallmarks of Aging: An Expanding Universe

10.1016/j.cell.2022.11.001 · 2023 · External reference

Age at Incident Treatment of Hypertension and Risk of Cancer: A Population Study

10.1007/s10552-009-9374-3 · 2009 · External reference

The Underlying Mechanisms for Development of Hypertension in the Metabolic Syndrome

10.1186/1475-2891-7-10 · 2008 · External reference

Hypertension in Metabolic Syndrome: Vascular Pathophysiology

10.1155/2013/230868 · 2013 · External reference

10.2337/dc12‐0336

10.2337/dc12‐0336 · External reference

Metabolic Syndrome and Obesity‐Related Cancer Risk and Survival: An Umbrella Review of Systematic Reviews With Meta‐Analysis of Observational Studies

10.1111/obr.70073 · 2026 · External reference

Salt, Blood Pressure and Cardiovascular Disease

10.1097/hco.0b013e32814f1d8c · 2007 · External reference

Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet

10.1056/nejm200101043440101 · 2001 · External reference

Unresolved reference

2018 · External reference

Adherence to Dietary Approaches to Stop Hypertension (DASH)‐Style Diet and the Risk of Cancer: A Systematic Review and Meta‐Analysis of Cohort Studies

10.1080/07315724.2018.1554460 · 2019 · External reference

Diet Quality as Assessed by the Healthy Eating Index, the Alternate Healthy Eating Index, the Dietary Approaches to Stop Hypertension Score, and Health Outcomes: A Systematic Review and Meta‐Analysis of Cohort Studies

10.1016/j.jand.2014.12.009 · 2015 · External reference

10.1590/s1807‐59322005000300010

10.1590/s1807‐59322005000300010 · External reference

The Tripartite Model for Assessing Symptoms of Depression and Anxiety: Psychometric Properties of the Chinese Version of the Mood and Anxiety Symptoms Questionnaire in Patients With Essential Hypertension

10.1097/jcn.0000000000000193 · 2015 · External reference

10.1007/s12160‐013‐9526‐2

10.1007/s12160‐013‐9526‐2 · External reference

10.1016/j.atherosclerosis.2016.12.003

10.1016/j.atherosclerosis.2016.12.003 · External reference

10.1038/s41380‐019‐0595‐x

10.1038/s41380‐019‐0595‐x · External reference

10.1371/journal.pone.0324027

10.1371/journal.pone.0324027 · External reference

10.1007/s12094‐020‐02488‐3

10.1007/s12094‐020‐02488‐3 · External reference

10.1016/j.tcb.2022.07.004

10.1016/j.tcb.2022.07.004 · External reference

10.1016/j.cbi.2010.04.024

10.1016/j.cbi.2010.04.024 · External reference

10.1073/pnas.1803725115

10.1073/pnas.1803725115 · External reference

10.1016/j.bbamcr.2018.05.015

10.1016/j.bbamcr.2018.05.015 · External reference

10.2174/1568009622666220215143805

10.2174/1568009622666220215143805 · External reference

10.1242/jcs.194803

10.1242/jcs.194803 · External reference

10.1007/s10286‐020‐00724‐y

10.1007/s10286‐020‐00724‐y · External reference

10.1038/s41598‐017‐02289‐9

10.1038/s41598‐017‐02289‐9 · External reference

10.1093/cvr/cvae205

10.1093/cvr/cvae205 · External reference

10.3390/molecules30102145

10.3390/molecules30102145 · External reference

10.1016/j.pbiomolbio.2023.03.003

10.1016/j.pbiomolbio.2023.03.003 · External reference

10.1186/s13578‐023‐01098‐0

10.1186/s13578‐023‐01098‐0 · External reference

10.1016/j.phrs.2025.107634

10.1016/j.phrs.2025.107634 · External reference

10.1126/science.1124234

10.1126/science.1124234 · External reference

10.1016/j.semcancer.2020.05.004

10.1016/j.semcancer.2020.05.004 · External reference

10.3389/fcimb.2023.1140126

10.3389/fcimb.2023.1140126 · External reference

10.1038/s42255‐025‐01287‐w

10.1038/s42255‐025‐01287‐w · External reference

10.1161/circresaha.121.319816

10.1161/circresaha.121.319816 · External reference

10.3390/nu12102982

10.3390/nu12102982 · External reference

10.1089/ars.2020.8104

10.1089/ars.2020.8104 · External reference

10.1016/j.mayocp.2020.03.037

10.1016/j.mayocp.2020.03.037 · External reference

10.1007/s11010‐023‐04923‐9

10.1007/s11010‐023‐04923‐9 · External reference

10.1177/11782234211015753

10.1177/11782234211015753 · External reference

10.1016/j.ijcard.2019.01.082

10.1016/j.ijcard.2019.01.082 · External reference

10.1002/cam4.71021

10.1002/cam4.71021 · External reference

10.1097/00004872‐200204000‐00003

10.1097/00004872‐200204000‐00003 · External reference

10.3390/biom14111374

10.3390/biom14111374 · External reference

10.1677/joe.0.0670143

10.1677/joe.0.0670143 · External reference

10.1056/nejm197709152971110

10.1056/nejm197709152971110 · External reference

10.1161/hypertensionaha.123.21119

10.1161/hypertensionaha.123.21119 · External reference

10.1111/j.1365‐2125.2012.04417.x

10.1111/j.1365‐2125.2012.04417.x · External reference

10.1200/jco.2005.04.5740

10.1200/jco.2005.04.5740 · External reference

10.1080/02841860802314720

10.1080/02841860802314720 · External reference

10.1186/s12885‐023‐10571‐5

10.1186/s12885‐023‐10571‐5 · External reference

10.1007/s11864‐023‐01094‐z

10.1007/s11864‐023‐01094‐z · External reference

10.1007/s11255‐022‐03151‐2

10.1007/s11255‐022‐03151‐2 · External reference

10.5935/abc.20150011

10.5935/abc.20150011 · External reference

Baroreflex Failure: A Neglected Type of Secondary Hypertension

2004 · External reference

10.1093/jnci/djr128

10.1093/jnci/djr128 · External reference

Immune Checkpoint Inhibitors Do Not Increase Short‐Term Risk of Hypertension in Cancer Patients: A Systematic Literature Review and Meta‐Analysis

10.1161/hypertensionaha.122.19865 · 2022 · External reference

The Incidence and Relative Risk of Major Adverse Cardiovascular Events and Hypertension in Patients Treated With Immune Checkpoint Inhibitors Plus Tyrosine‐Kinase Inhibitors for Solid Tumors: A Systemic Review and Meta‐Analysis

10.1080/14737140.2024.2357814 · 2024 · External reference

10.1097/hjh.0b013e3282f3ef5e

10.1097/hjh.0b013e3282f3ef5e · External reference

10.18632/aging.102699

10.18632/aging.102699 · External reference

10.1007/s10552‐022‐01570‐1

10.1007/s10552‐022‐01570‐1 · External reference

10.1038/sj.jhh.1001015

10.1038/sj.jhh.1001015 · External reference

10.3390/ijms25063442

10.3390/ijms25063442 · External reference

10.1371/journal.pone.0119775

10.1371/journal.pone.0119775 · External reference

10.1097/md.0000000000016047

10.1097/md.0000000000016047 · External reference

10.1016/j.critrevonc.2017.12.003

10.1016/j.critrevonc.2017.12.003 · External reference

10.1136/bmjopen‐2019‐036164

10.1136/bmjopen‐2019‐036164 · External reference

10.1002/bjs.10988

10.1002/bjs.10988 · External reference

10.1007/s10552‐017‐0857‐3

10.1007/s10552‐017‐0857‐3 · External reference

10.1093/ajh/hpae101

10.1093/ajh/hpae101 · External reference

10.1161/hypertensionaha.120.14820

10.1161/hypertensionaha.120.14820 · External reference

10.1001/jama.279.13.1000

10.1001/jama.279.13.1000 · External reference

10.1177/1060028018814684

10.1177/1060028018814684 · External reference

10.1186/s12894‐018‐0318‐7

10.1186/s12894‐018‐0318‐7 · External reference

10.1001/jamainternmed.2013.9071

10.1001/jamainternmed.2013.9071 · External reference

10.1002/ijc.33379

10.1002/ijc.33379 · External reference

10.3389/fphar.2020.539261

10.3389/fphar.2020.539261 · External reference

10.1097/hjh.0000000000003480

10.1097/hjh.0000000000003480 · External reference

10.1161/hyp.0000000000000249

10.1161/hyp.0000000000000249 · External reference

10.1093/eurheartj/ehac244

10.1093/eurheartj/ehac244 · External reference

10.1016/j.mayocp.2014.08.011

10.1016/j.mayocp.2014.08.011 · External reference

Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement From the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology

10.1002/ejhf.2017 · 2020 · External reference